---
url: https://www.servicesaustralia.gov.au/pb125
title: Atypical haemolytic uraemic syndrome (aHUS) - eculizumab or ravulizumab - continuing authority application form (PB125) - Services AustraliaServices AustraliaServices Australia
scrapedAt: 2026-02-17T02:22:42.240Z
source: servicesaustralia.gov.au
---
# Atypical haemolytic uraemic syndrome (aHUS) - eculizumab or ravulizumab - continuing authority application form (PB125)

Use this form to apply to continue PBS-subsidised treatment with eculizumab or ravulizumab for aHUS.

How to use our forms

You must [download our forms and fill them in](/how-to-use-our-forms) so they are processed quickly. You can also electronically sign some of our forms. We have help available if you use assistive technology or need an interpreter.

You can [upload this form in HPOS](/upload-forms-hpos).

Download and complete the [atypical haemolytic uraemic syndrome (aHUS) - eculizumab or ravulizumab - continuing authority application form](/sites/default/files/2025-05/pb125-2506en-f.pdf "PDF document").
